Jenburkt Pharmaceuticals Limited (JENBURPH.BO)
INR 1092.3
(4.74%)
INR 1092.3
(4.74%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 58.86 INR | 5.56% |
| 2022 | 55.76 INR | 14.78% |
| 2021 | 48.58 INR | 35.09% |
| 2020 | 35.96 INR | 10.99% |
| 2019 | 32.40 INR | -24.9% |
| 2018 | 43.14 INR | 15.04% |
| 2017 | 37.50 INR | 29.09% |
| 2016 | 29.05 INR | 25.32% |
| 2015 | 23.18 INR | 11.71% |
| 2014 | 20.75 INR | 28.48% |
| 2013 | 16.15 INR | 20.79% |
| 2012 | 13.37 INR | 3.72% |
| 2011 | 12.89 INR | -0.39% |
| 2010 | 12.94 INR | 61.95% |
| 2009 | 7.99 INR | 162.83% |
| 2008 | 3.04 INR | 10.95% |
| 2007 | 2.74 INR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 16.80 INR | -5.94% |
| 2023 Q3 | 11.78 INR | -28.99% |
| 2023 FY | - INR | 5.56% |
| 2023 Q1 | 12.17 INR | -12.07% |
| 2023 Q2 | 16.59 INR | 36.32% |
| 2023 Q4 | 17.86 INR | 51.61% |
| 2022 Q4 | 13.84 INR | 16.3% |
| 2022 Q1 | 12.97 INR | 72.7% |
| 2022 Q3 | 11.90 INR | -20.45% |
| 2022 FY | - INR | 14.78% |
| 2022 Q2 | 14.96 INR | 15.34% |
| 2021 FY | - INR | 35.09% |
| 2021 Q1 | 10.13 INR | 19.88% |
| 2021 Q2 | 17.37 INR | 71.47% |
| 2021 Q3 | 13.57 INR | -21.88% |
| 2021 Q4 | 7.51 INR | -44.66% |
| 2020 FY | - INR | 10.99% |
| 2020 Q1 | 2.20 INR | -78.13% |
| 2020 Q2 | 12.36 INR | 461.82% |
| 2020 Q3 | 12.96 INR | 4.85% |
| 2020 Q4 | 8.45 INR | -34.8% |
| 2019 Q1 | 0.13 INR | -99.13% |
| 2019 Q4 | 10.06 INR | -0.49% |
| 2019 Q2 | 12.10 INR | 9207.69% |
| 2019 Q3 | 10.11 INR | -16.45% |
| 2019 FY | - INR | -24.9% |
| 2018 Q2 | 12.52 INR | 112.93% |
| 2018 FY | - INR | 15.04% |
| 2018 Q4 | 15.02 INR | 54.53% |
| 2018 Q1 | 5.88 INR | -51.6% |
| 2018 Q3 | 9.72 INR | -22.36% |
| 2017 Q3 | 9.89 INR | -53.89% |
| 2017 Q4 | 12.15 INR | 22.85% |
| 2017 Q2 | 21.45 INR | 446.53% |
| 2017 Q1 | -6.19 INR | -181.45% |
| 2017 FY | - INR | 29.09% |
| 2016 Q1 | 4.19 INR | 50.72% |
| 2016 Q4 | 7.60 INR | 19.69% |
| 2016 Q3 | 6.35 INR | -41.64% |
| 2016 Q2 | 10.88 INR | 159.67% |
| 2016 FY | - INR | 25.32% |
| 2015 Q4 | 2.78 INR | -63.08% |
| 2015 FY | - INR | 11.71% |
| 2015 Q1 | 5.49 INR | 14.14% |
| 2015 Q2 | 7.38 INR | 34.43% |
| 2015 Q3 | 7.53 INR | 2.03% |
| 2014 Q1 | 3.20 INR | -35.61% |
| 2014 FY | - INR | 28.48% |
| 2014 Q3 | 6.49 INR | -7.02% |
| 2014 Q4 | 4.81 INR | -25.89% |
| 2014 Q2 | 6.98 INR | 118.13% |
| 2013 Q4 | 4.97 INR | 18.33% |
| 2013 FY | - INR | 20.79% |
| 2013 Q3 | 4.20 INR | -15.32% |
| 2013 Q2 | 4.96 INR | 146.77% |
| 2013 Q1 | 2.01 INR | -44.01% |
| 2012 Q2 | 4.89 INR | 174.72% |
| 2012 Q1 | 1.78 INR | 0.0% |
| 2012 FY | - INR | 3.72% |
| 2012 Q4 | 3.59 INR | 15.81% |
| 2012 Q3 | 3.10 INR | -36.61% |
| 2011 Q3 | 2.46 INR | 0.0% |
| 2011 Q4 | - INR | -100.0% |
| 2011 FY | - INR | -0.39% |
| 2010 FY | - INR | 61.95% |
| 2009 FY | - INR | 162.83% |
| 2008 FY | - INR | 10.95% |
| 2007 FY | - INR | 0.0% |